2025-08-13
9 分钟I'm Steve Strogatz. And I'm Jana Levin.
And this season on The Joy of Why from Quantum Magazine, we're sitting down together.
We have our own research areas,
but we don't always get the chance to speak deeply about science and math beyond our fields.
We'll ask researchers about moments big and small that inspire them and lead to incredible discoveries.
Lots of science news outlets provide coverage on applied work like health and tech,
but we cover big questions in the study of life, reality, numbers, and information.
We hope these stories spark your curiosity, too.
Join us for The Joy of Why from Quantum Magazine.
For Scientific American Science Quickly, I'm Rachel Feltman.
When it comes to birth control, men have exactly two reliable options.
Condoms or a vasectomy.
That's it.
For decades, researchers have been working to expand those choices, but progress has been slow.
Now, a new pill for men has just passed its first safety trial in humans.
What's particularly exciting about this daily pill,
which works by blocking a key step in sperm production, is that it's hormone-free.
Here to tell us more about the latest progress on male contraception is Hannah Seo,
a freelance science journalist based in Brooklyn.
Hannah, thanks so much for coming on to chat today.